SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-20-008650
Filing Date
2020-04-06
Accepted
2020-04-06 16:30:19
Documents
1
Period of Report
2020-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FILED CURRENT REPORT ea120418-8ka_relmada.htm 8-K/A 19477
  Complete submission text file 0001213900-20-008650.txt   20725
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39082 | Film No.: 20777303
SIC: 2834 Pharmaceutical Preparations